Prosecution Insights
Last updated: May 29, 2026

Examiner: SANFORD, DIANA PATRICIA

Tech Center 1600 • Art Units: 1687

This examiner grants 83% of resolved cases

Performance Statistics

83.3%
Allow Rate
+23.3% vs TC avg
48
Total Applications
+25.0%
Interview Lift
1603
Avg Prosecution Days
Based on 6 resolved cases, 2023–2026

Rejection Statute Breakdown

13.2%
§101 Eligibility
6.6%
§102 Novelty
72.4%
§103 Obviousness
0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17662022 CLOSED LOOP CONTINUOUS APTAMER DEVELOPMENT SYSTEM Non-Final OA X Development LLC
17349785 METHODS FOR DESIGNING ANTIBODY SMALL-MOLECULE CONJUGATES Non-Final OA California Institute of Technology
17792639 MOLECULE DESIGN Non-Final OA Flagship Pioneering Innovations VI, LLC
17670299 METHOD FOR DETERMINING PROCESS VARIABLES IN CELL CULTIVATION PROCESSES Final Rejection Hoffmann-La Roche Inc.
17884852 CELL CULTURE PROCESS SEARCH METHOD, CELL CULTURE PROCESS SEARCH PROGRAM, CELL CULTURE PROCESS SEARCH DEVICE, AND LEARNED MODEL Non-Final OA FUJIFILM Corporation
17565910 INFORMATION PROCESSING METHOD AND DEVICE Non-Final OA Baidu.com Times Technology (Beijing) Co., Ltd.
17723939 COMPUTATIONAL METHOD FOR CHARACTERIZING A BIOPOLYMER PROPERTY OF A BIOPOLYMER Non-Final OA Robert Bosch GmbH
17616287 Thermodynamic Formulation for Langmuir Adsorption Isotherms Non-Final OA Texas Tech University System
17795091 METHOD FOR OPTIMIZING MANUFACTURING CONDITION FOR POLYARYLENE SULFIDE RESIN COMPOSITE, AND METHOD FOR MANUFACTURING RESIN COMPOSITE Non-Final OA National Institute of Advanced Industrial Science and Technology
17407013 SPECIFICALLY-SHAPED CRYSTAL OF COMPOUND AND METHOD FOR PRODUCING SAME Non-Final OA The University of Tokyo
17614510 Adhesive Selection Method, Adhesion Complex, and Production Method for Adhesion Complex Non-Final OA SIKA TECHNOLOGY AG
17490425 ESTIMATING CARDIAC PARAMETERS WHEN PERFORMING AN ACTIVITY USING A PERSONALIZED CARDIOVASCULAR HEMODYNAMIC MODEL Non-Final OA Tata Consultancy Services Limited
17746712 PRECISION ENRICHMENT OF PATHOLOGY SPECIMENS Non-Final OA Foundation Medicine, Inc.
17429343 BLOOD CELL-FREE DNA-BASED METHOD FOR PREDICTING PROGNOSIS OF LIVER CANCER TREATMENT Non-Final OA UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
17623396 ESTIMATING A QUANTITY OF MOLECULES IN A SAMPLE Final Rejection BP CORPORATION NORTH AMERICA INC.
17910556 METHOD AND SYSTEM OF FOR PREDICTING DISEASE RISK BASED ON MULTIMODAL FUSION Non-Final OA SHANDONG UNIVERSITY
17531868 MULTIPLEXED ASSAY KITS FOR EVALUATION OF SYSTEMIC LUPUS ERYTHEMATOSUS Final Rejection Meso Scale Technologies, LLC.
17502064 AFLATOXIN CONTAMINATION RISK WARNING MOLECULE AND USE THEREOF Final Rejection OIL CROPS RESEARCH INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES
17598923 DETERMINING HEMATOLOGIC TOXICITY RISK FOLLOWING RADIOTHERAPY Non-Final OA Elekta, Inc.
17696197 SYSTEM USING MACHINE LEARNING MODEL TO DETERMINE FOOD ITEM RIPENESS Non-Final OA Apeel Technology, Inc.
17904911 SELECTING A CELL LINE FOR AN ASSAY Non-Final OA BenevolentAI Technology Limited
17746359 HTP GENOMIC ENGINEERING PLATFORM Non-Final OA Gingko Bioworks, Inc.
17769727 CLINICAL VARIANT CLASSIFIER MODELS, MACHINE LEARNING SYSTEMS AND METHODS OF USE Non-Final OA NemaMetrix, Inc
17562589 SYSTEM FOR DETERMINING FEATURE OF ACRYLONITRILE BUTADIENE STYRENE USING ARTIFICIAL INTELLECTUAL AND OPERATION METHOD THEREOF Final Rejection DAEJIN ADVANCED MATERIALS Inc.
17432734 METHOD FOR ANALYZING DIFFERENTIATION OF METABOLITES IN URINE SAMPLE BETWEEN DIFFERENT GROUPS Non-Final OA Samsung Medical Center
17601060 CELL CULTURE SYSTEMS AND USES THEREOF Non-Final OA FLASKWORKS, LLC
17441094 Method of DNA Base-Calling from a Nanochannel DNA Sequencer Final Rejection Bo MA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month